OmniCyte
- Biotech or pharma, therapeutic R&D
OmniCyte is a preclinical stage, immunology based, biotechnology company located in Branford Connecticut. The company was founded with a mission to develop targeted treatments to address unmet needs in cancer. Our therapeutics are developed on our proprietary, Targeted Immune Activation, platform technology. The platform consists of a bi-specific protein complex, with a conserved domain that activates an adaptive, as well as an innate, immune response through the dendritic cell, and a variable targeting domain that can be engineered to target numerous tumor types and pathogens.
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}